Search Within

Aaron David Viny

  1. "2018"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (1)
Groups
  1. Adult Leukemia (7)
  2. Center for Hematologic Malignancies (7)
  3. Department of Medicine (7)
  4. Executive Committee, Center for Hematologic Malignancies (7)
  5. GSK Faculty (7)
  6. Hematologic Malignancies, Division of (7)

More Groups

People
  1. Ross Levine (7)
  2. Aaron Goldberg (2)
  3. Andrew Dunbar (2)
  4. Bartlomiej Getta (2)
  5. Christopher Famulare (2)
  6. Erin McGovern (2)

More People

Years
  1. 2018 (7)
Publications
  1. Blood (4)
  2. Cancer Research (1)
  3. Current Opinion in Hematology (1)
  4. Journal of Molecular Diagnostics (1)
Publishers
  1. American Society of Hematology (4)
  2. American Association for Cancer Research (1)
  3. Elsevier Science, Inc. (1)
  4. Lippincott Williams & Wilkins, Ltd. (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sphingolipid metabolism determines the efficacy of nanoliposomal ceramide in acute myeloid leukemia
    Meeting Abstract

    Annageldiyev, C.; Sharma, A.; Barth, B. M.; Fox, T. E.; Deering, T.; Devine, V.; Keasey, N. R.; Stern, S. T.; Young, M. M.; Wang, H. G. W.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Combinatorial genetics uncovers novel targets for the treatment of NPM1/cohesin mutated AML
    Meeting Abstract

    Meyer, A. E.; Stelloh, C.; Fisher, J. B.; Pulakanti, K.; Vassiliou, G. S.; Viny, A. D.; Levine, R. L.; Rao, S.
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • YY1 controls hematopoietic stem cell quiescence by repressing cohesin expression
    Meeting Abstract

    Lu, Z.; Assumpcao, A. L. F. V.; Viny, A. D.; Levine, R. L.; Pan, X.
    Blood (2018)

    Fulltext@MSK | Save
  • Longitudinal monitoring of AML tumors with high-throughput single-cell DNA sequencing reveals rare clones prognostic for disease progression and therapy response
    Meeting Abstract

    Eastburn, D. J.; McMahon, C. M.; Viny, A.; Bowman, R.; Miles, L.; Durruthy-Durruthy, R.; Levine, R. L.; Carroll, M.; Smith, C. C.; Perl, A. E.
    Journal of Molecular Diagnostics (2018)

    Fulltext@MSK | Save
  • Cohesin mutations in myeloid malignancies made simple
    Journal Article

    Viny, A. D.; Levine, R. L.
    Current Opinion in Hematology (2018)

    Fulltext@MSK | Save